Abstract:Background: Radioresistance is the leading cause of treatment failure for nasopharyngeal carcinoma (NPC). Therefore, screening the critical regulators in radioresistance and revealing the underlying mechanisms is imperative for improvement of therapeutical efficacy in NPC. Materials and methods: Our previous study has proved that miR-181a may serve as a pro-radioresistant miRNA. In this study, we explored the expression of miR-181a in NPC, especially in radioresistant NPC samples, by qPCR. Moreover, the clinical significance of miR-181a level was also analyzed. Furthermore, the functions of miR-181a, both in vitro and in vivo, were detected via a serial of assays such as CCK-8, plate clone survival, apoptosis, and xenograft tumor model. The downstream target of miR-181a was also validated by dual luciferase reporter assay and the roles of miR-181a's target in the regulation of NPC radioresistance were investigated. Results: The results revealed that miR-181a was significantly upregulated in NPC, especially in radioresistant NPC. MiR-181a level is positively correlated to lymph node metastasis and advanced TNM stages and negatively associated with overall survival rate in NPC. Ectopic expression of miR-181a in radiosensitive NPC cells, or overexpression of miR-181a inhibitor in radioresistant NPC cells, could enhance or impair the radioresistance of NPC cells supported by the results from both in vitro and in vivo, respectively. Mechanistically, dual luciferase report assay indicated that miR-181a could directly target RKIP. Moreover, both in vitro and in vivo experimental outcomes indicated that RKIP restoration and knockdown could antagonize the effects of miR-181a and miR-181a inhibitor in the regulation of NPC radioresistance. Conclusion: Collectively, the findings of this study proved that miR-181a is upregulated and promotes radioresistance by targeting RKIP in NPC. Targeting miR-181a/RKIP axis may be a valid path for reinforcing radiosensitivity and eventually improving the outcomes of clinical treatment in NPC.

Mir-1278 Sensitizes Nasopharyngeal Carcinoma Cells to Cisplatin and Suppresses Autophagy Via Targeting ATG2B.

MiRNA-296-5p promotes the sensitivity of nasopharyngeal carcinoma cells to cisplatin via targeted inhibition of STAT3/KLF4 signaling axis

MiR-126 Enhances Cisplatin Chemosensitivity in Hepatocellular Carcinoma Cells by Targeting IRS1

miR-128-3p increases the radiosensitivity in nasopharyngeal carcinoma via regulating vascular endothelial growth factor C

Exosomal transfer of miR‐106a‐5p contributes to cisplatin resistance and tumorigenesis in nasopharyngeal carcinoma

MicroRNA-29c Enhances the Sensitivities of Human Nasopharyngeal Carcinoma to Cisplatin-Based Chemotherapy and Radiotherapy

Cisplatin-induced Downregulation of Mir-199A-5p Increases Drug Resistance by Activating Autophagy in HCC Cell.

MiR-634 Sensitizes Nasopharyngeal Carcinoma Cells to Paclitaxel and Inhibits Cell Growth Both in Vitro and in Vivo.

Retraction: MiR-125b Increases Nasopharyngeal Carcinoma Radioresistance by Targeting A20/NF-κB Signaling Pathway.

Mir-185-3p Regulates Nasopharyngeal Carcinoma Radioresistance by Targeting WNT2B in Vitro.

MiR-138-1-3p Alters the Stemness and Radiosensitivity of Tumor Cells by Targeting CRIPTO and the JAK2/STAT3 Pathway in Nasopharyngeal Carcinoma.

miR-137/ERRα axis mediates chemoresistance of nasopharyngeal carcinoma cells

Mir-181A Upregulation Promotes Radioresistance of Nasopharyngeal Carcinoma by Targeting RKIP

Retracted: Mir-125b Increases Nasopharyngeal Carcinoma Radioresistance By Targeting A20/Nf-Kappa B Signaling Pathway (Retracted Article. See Vol. 17, Pg. 2490, 2018)

MiR-302c-5p affects the stemness and cisplatin resistance of nasopharyngeal carcinoma cells by regulating HSP90AA1

Autophagy Inhibition Impairs the Epithelial-Mesenchymal Transition and Enhances Cisplatin Sensitivity in Nasopharyngeal Carcinoma

Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy

Regulation of Autophagy by Mir-30D Impacts Sensitivity of Anaplastic Thyroid Carcinoma to Cisplatin.

A Directly Negative Interaction of Mir-203 and ZEB2 Modulates Tumor Stemness and Chemotherapy Resistance in Nasopharyngeal Carcinoma

MicroRNA-19b-3p Regulates Nasopharyngeal Carcinoma Radiosensitivity by Targeting TNFAIP3/NF-κB Axis

Mirna-203 Reduces Nasopharyngeal Carcinoma Radioresistance by Targeting Il8/Akt Signaling